King Faisal Hospital Expands Healthcare with New Partnerships
Riyadh, Tuesday, 28 October 2025.
King Faisal Specialist Hospital signed agreements to enhance specialized care, focusing on robotic surgery and CAR-T cell therapies, aligning with Saudi Arabia’s Vision 2030 for healthcare transformation.
Overview of Agreements Signed
On October 27, 2025, King Faisal Specialist Hospital and Research Centre (KFSHRC) signed four significant agreements at the Global Health Exhibition 2025. These agreements are pivotal in expanding specialized medical care access, aligning with Saudi Arabia’s Vision 2030 healthcare transformation goals [1].
Robotic Surgery Training Enhancement
A noteworthy collaboration was established with Zimmer GmbH (Zimmer Biomet), focusing on advancing robotic surgery training and AI technology integration in clinical settings. The partnership includes organizing non-cadaveric training programs at KFSHRC to enhance surgical competencies and promote knowledge transfer in precision surgery [2].
Development of CAR-T Cell Therapies
In collaboration with U.S. biotechnology company Kure Cells, KFSHRC aims to develop and locally manufacture ultra-fast CAR-T cell therapies. This initiative is expected to significantly accelerate treatment access in Saudi Arabia, reducing the reliance on international centers and establishing the region as a hub for cell and gene therapy [1].
Strategic Healthcare Partnerships
Additional agreements include a memorandum of understanding with Medtronic to support advanced cardiac catheterization services, enhancing KFSHRC’s global leadership in cardiac care. Furthermore, a cooperation agreement with the Center for National Health Insurance was signed to improve healthcare efficiency, sustainability, and innovation within Saudi Arabia [1][2].